The lncRNA LENT interacts with DHX36 to regulate translation and suppress autophagy in melanoma.
RNA-seq (gene expression) · human · 33 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- MelanomaThis series is part of our curated briefing on it.
- Samples
- 33 samples: 11 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE270716_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1128071 and SRA study SRP516030. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 33 samples.
How we read this: 11 replicated groups read from 33 sample titles; they account for 33 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8350530 501M_ASO_NEG_1 501M_ASO_NEG
- GSM8350531 501M_ASO_NEG_2 501M_ASO_NEG
- GSM8350532 501M_ASO_NEG_3 501M_ASO_NEG
- GSM8350533 501M_ASO_LENT_1 501M_ASO_LENT
- GSM8350534 501M_ASO_LENT_2 501M_ASO_LENT
- GSM8350535 501M_ASO_LENT_3 501M_ASO_LENT
- GSM8350536 501M_shCtrl_IgG_1 501M_shCtrl_IgG
- GSM8350537 501M_shCtrl_IgG_2 501M_shCtrl_IgG
- GSM8350538 501M_shCtrl_IgG_3 501M_shCtrl_IgG
- GSM8350539 501M_shCtrl_DHX_1 501M_shCtrl_DHX
- GSM8350540 501M_shCtrl_DHX_2 501M_shCtrl_DHX
- GSM8350541 501M_shCtrl_DHX_3 501M_shCtrl_DHX
- GSM8350542 501M_shLENT_DHX_1 501M_shLENT_DHX
- GSM8350543 501M_shLENT_DHX_2 501M_shLENT_DHX
- GSM8350544 501M_shLENT_DHX_3 501M_shLENT_DHX
- GSM8350545 501M_shCtrl_80S_1 501M_shCtrl_80S
- GSM8350546 501M_shCtrl_Light_1 501M_shCtrl_Light
- GSM8350547 501M_shCtrl_Heavy_1 501M_shCtrl_Heavy
- GSM8350548 501M_shCtrl_80S_2 501M_shCtrl_80S
- GSM8350549 501M_shCtrl_Light_2 501M_shCtrl_Light
- GSM8350550 501M_shCtrl_Heavy_2 501M_shCtrl_Heavy
- GSM8350551 501M_shCtrl_80S_3 501M_shCtrl_80S
- GSM8350552 501M_shCtrl_Light_3 501M_shCtrl_Light
- GSM8350553 501M_shCtrl_Heavy_3 501M_shCtrl_Heavy
- GSM8350554 501M_shLENT_80S_1 501M_shLENT_80S
- GSM8350555 501M_shLENT_Light_1 501M_shLENT_Light
- GSM8350556 501M_shLENT_Heavy_1 501M_shLENT_Heavy
- GSM8350557 501M_shLENT_80S_2 501M_shLENT_80S
- GSM8350558 501M_shLENT_Light_2 501M_shLENT_Light
- GSM8350559 501M_shLENT_Heavy_2 501M_shLENT_Heavy
- GSM8350560 501M_shLENT_80S_3 501M_shLENT_80S
- GSM8350561 501M_shLENT_Light_3 501M_shLENT_Light
- GSM8350562 501M_shLENT_Heavy_3 501M_shLENT_Heavy
- GSE140150 A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 6 samples same disease briefing · shares suppress, melanoma
- GSE12391 Melanoma: comparison between common nevi, radial/vertical growth phase melanoma, metastases and dysplastic nevi 114 samples same disease briefing · shares melanoma
- GSE134459 Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 73 samples same disease briefing · shares melanoma
- GSE230489 RNA-sequencing of cutaneous melanoma and non-small cell lung cancer biopsies 38 samples same disease briefing · shares melanoma
- GSE100797 Mutational and neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma 25 samples same disease briefing · shares melanoma
- GSE123728 Clinical and Immunologic Activity of a Single Dose of Neoadjuvant PD-1 Blockade and Predictors of Clinical Outcomes in Resectable Melanoma 24 samples same disease briefing · shares melanoma
- GSE130956 Investigation of ST8SIA1 expression in icaritin-treated and untreated melanoma cell lines 12 samples same disease briefing · shares melanoma
- GSE317605 A Phase II Trial of Pembrolizumab plus Granulocyte Macrophage Colony Stimulating Factor in Advanced Biliary Cancer [CITE-Seq] 168 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.